Local transport company Thomson Coachlines has capitalized on Skin Elements new all-natural disinfectant to save time and money post COVID.

COVID-19 restrictions have been largely lifted worldwide, but the need to disinfect and clean with demand for disinfectants to help curtail the spread of the viruses, bacteria and germs remains high.

Buses need to be disinfected daily, and Thomson previously used normal chemical disinfectants which put buses out of action for two hours, degraded the upholstery (causing a $40,000 refit) and left unpleasant smells for passengers.

But now the company has adopted Skin Elements’ (ASX:SKN) SuprCuvr product which disinfects the coaches within 10 minutes, causes no damage to upholstery and offers a higher level of protection with 99.99999% effectiveness against COVID-19 and bacteria and germ killing power.

Commercialising opportunities abound

After 15 years of research and development, Skin Elements is switching to a focus on commercialisation of their three all-natural product ranges including, non-steroidal therapeutic creams (PapayaActivs) for eczema, psoriasis and other skin conditions, all-natural hypoallergenic sunscreen (Soléo Organics), and the extremely effective plant-based hospital grade disinfectant SuprCuvr.

The company secured Australian Therapeutic Goods Administration (TGA) registration for SuprCuvr as a hospital-grade disinfectant product against COVID-19 & bacteria in September 2021 – a critical step to commercialisation for the product in hospitals and aged-care homes

And in March, they produced 120,000 litres of SuprCuvr in its first major sales order with Australian medical distributor Pacific Health Care.

Now the company is pursuing commercialisation, confident the combination of high efficacy in a 100% plant-based formula is a significant market opportunity in manufacturing, childcare, and food production and handling sectors.




This article was developed in collaboration with Skin Elements Limited, a Stockhead advertiser at the time of publishing.


This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.